11.82

11.40% 1.21

After Hours: 11.59 -0.23 -1.95%

Beta Bionics Inc (BBNX)

Overview News Price History Discussions Forecast

Beta Bionics Inc stock is traded at $11.82, with a volume of 1.13M. It is up +11.40% in the last 24 hours and down -3.11% over the past month. Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.

Previous Close:

$10.61

Open:

$11.21

24h Volume:

1.13M

Relative Volume:

1.11

Market Cap:

$526.72M

Revenue:

$110.24M

Net Income/Loss:

$-66.44M

P/E Ratio:

-7.8221

EPS:

-1.5111

Net Cash Flow:

$-61.12M

1W Performance:

+24.95%

1M Performance:

-3.11%

6M Performance:

-62.38%

1Y Performance:

-23.79%

1-Day Range:

$11.01

$12.42

1-Week Range:

$9.03

$12.42

52-Week Range:

$8.80

$32.71

Beta Bionics Inc Stock (BBNX) Company Profile

Name

Beta Bionics Inc

Sector

Healthcare (1108)

Industry

Medical Devices (143)

Phone

949-427-7785

Address

11 HUGHES, IRVINE

Employee

423

Twitter

Next Earnings Date

2026-04-21

Latest SEC Filings

BBNX's Discussions on Twitter

Compare BBNX vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BBNX Beta Bionics Inc	11.82	472.80M	110.24M	-66.44M	-61.12M	-1.5111
ABT Abbott Laboratories	87.41	152.88B	45.13B	6.28B	7.38B	3.5895
SYK Stryker Corp	316.48	120.18B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	78.60	100.34B	35.48B	4.64B	5.41B	3.582
BSX Boston Scientific Corp	57.78	84.95B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	85.78	47.91B	6.30B	1.07B	1.09B	1.8406

Beta Bionics Inc Stock (BBNX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-09-26	Initiated	UBS	Buy
Jan-27-26	Initiated	TD Cowen	Hold
Jan-09-26	Downgrade	BofA Securities	Buy → Neutral
Oct-21-25	Resumed	Stifel	Buy
Oct-01-25	Upgrade	Goldman	Neutral → Buy
Jun-16-25	Initiated	Truist	Buy
Jun-12-25	Initiated	Lake Street	Buy
May-30-25	Initiated	Goldman	Neutral
May-30-25	Initiated	Wolfe Research	Outperform
Feb-24-25	Initiated	BofA Securities	Buy
Feb-24-25	Initiated	Lake Street	Buy
Feb-24-25	Initiated	Leerink Partners	Outperform
Feb-24-25	Initiated	Piper Sandler	Overweight
Feb-24-25	Initiated	Stifel	Buy
Feb-20-25	Initiated	Ladenburg Thalmann	Neutral
Feb-20-25	Initiated	Robert W. Baird	Neutral

View All

Beta Bionics Inc Stock (BBNX) Latest News

May 23, 2026

BofA Securities Maintains Beta Bionics(BBNX.US) With Hold Rating, Raises Target Price to $13 - Moomoo

May 23, 2026

Piper Sandler Maintains Beta Bionics(BBNX.US) With Buy Rating, Maintains Target Price $20 - Moomoo

May 23, 2026

May 22, 2026

Beta Bionics | 8-K: Current report - Moomoo

May 22, 2026

Beta Bionics (NASDAQ: BBNX) investors approve directors and auditor - Stock Titan

May 22, 2026

Beta Bionics Updates Commercialization Timeline Expectations for Mint™, its Patch Pump in Development - Sahm

May 22, 2026

May 21, 2026

Beta Bionics Expects Commercialization of Mint Insulin Patch Pump in 2027 - Moomoo

May 21, 2026

[144] Beta Bionics, Inc. SEC Filing - Stock Titan

May 21, 2026

Beta Bionics says Mint commercialization expected by end-Q2 2027, subject to FDA clearance - TradingView

May 21, 2026

Mint patch pump launch target set for Q2 2027 by Beta Bionics (NASDAQ: BBNX) - Stock Titan

May 21, 2026

No-recharge insulin patch pump targets 2027 launch pending FDA clearance - Stock Titan

May 21, 2026

May 19, 2026

BBNX Maintains by B of A Securities -- Price Target Lowered to $11.00 - GuruFocus

May 19, 2026

May 18, 2026

Beta Bionics Price Target Cut to $11.00/Share From $23.00 by B of A Securities - Moomoo

May 18, 2026

Beta Bionics, Inc. Stock 12‑Month Price Target Cut to $19.18, Implies 103% Upside - TradingView

May 18, 2026

BofA Adjusts Price Target on Beta Bionics to $11 From $23 - Moomoo

May 18, 2026

BofA Securities Maintains Beta Bionics(BBNX.US) With Hold Rating, Cuts Target Price to $11 - Moomoo

May 18, 2026

May 16, 2026

BBNX Forecast — Price Target — Prediction for 2027 - TradingView

May 16, 2026

May 15, 2026

Beta Bionics | SCHEDULE 13G/A: Others - Moomoo

May 15, 2026

Eventide (BBNX) reports 5.95M shares — 13.4% stake in Beta Bionics - Stock Titan

May 15, 2026

RTW Investments reports 2.0M-share stake in Beta Bionics (NASDAQ: BBNX) - Stock Titan

May 15, 2026

May 13, 2026

Beta Bionics Touts Pharmacy Push, iLet Momentum and 2027 Mint Patch Pump Plans - Yahoo Finance

May 13, 2026

May 12, 2026

BBNX: Mint patch pump launch set for end of 2027, with pharmacy channel driving growth - TradingView

May 12, 2026

Farallon and Zone Holdings disclose ownership in Beta Bionics (BBNX) — 13G/A - Stock Titan

May 12, 2026

Here's Why We're Not Too Worried About Beta Bionics' (NASDAQ:BBNX) Cash Burn Situation - Yahoo Finance

May 12, 2026

May 11, 2026

Number of shareholders of Beta Bionics, Inc. – NASDAQ:BBNX - TradingView

May 11, 2026

May 08, 2026

Soleus group files 9.8% stake in Beta Bionics (NASDAQ: BBNX) - Stock Titan

May 08, 2026